Treatment of chronic hepatitis C by interferon for longer duration than six months
- 1 December 1996
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 41 (12) , 99S-102S
- https://doi.org/10.1007/bf02087883
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and DurationHepatology, 1996
- Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response ratesJournal of Hepatology, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial.1995
- Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trialHepatology, 1995
- Large-scale randomized evidence: Large, simple trials and overviews of trialsJournal of Clinical Epidemiology, 1995
- Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitisGastroenterology, 1994
- Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2bHepatology, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986